These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 1419901

  • 1. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
    Kiyokawa H, Ngo L, Kurosaki T, Rifkind RA, Marks PA.
    Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
    [Abstract] [Full Text] [Related]

  • 2. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
    Richon VM, Rifkind RA, Marks PA.
    Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
    [Abstract] [Full Text] [Related]

  • 3. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA, Michaeli J, Jackson J, Richon VM, Rifkind RA.
    Prog Clin Biol Res; 1989 Jul; 316B():171-81. PubMed ID: 2616574
    [Abstract] [Full Text] [Related]

  • 4. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA, Ramsay R, Sheffery M, Rifkind RA.
    Prog Clin Biol Res; 1987 Jul; 251():253-68. PubMed ID: 3481077
    [Abstract] [Full Text] [Related]

  • 5. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH, el-Naggar AK, Priebe W, Perez-Soler R.
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [Abstract] [Full Text] [Related]

  • 6. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX.
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [Abstract] [Full Text] [Related]

  • 7. Expression of the murine homologue of the cell cycle control protein p34cdc2 in T lymphocytes.
    Kim YH, Proust JJ, Buchholz MJ, Chrest FJ, Nordin AA.
    J Immunol; 1992 Jul 01; 149(1):17-23. PubMed ID: 1637418
    [Abstract] [Full Text] [Related]

  • 8. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA, Rifkind RA.
    Int J Cell Cloning; 1988 Jul 01; 6(4):230-40. PubMed ID: 3047266
    [Abstract] [Full Text] [Related]

  • 9. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE, Haspel HC, Peretz AM, Sonenberg M, Rifkind RA.
    Cancer Res; 1986 Mar 01; 46(3):1136-41. PubMed ID: 3455880
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
    Richon VM, Ramsay RG, Rifkind RA, Marks PA.
    Oncogene; 1989 Feb 01; 4(2):165-73. PubMed ID: 2648254
    [Abstract] [Full Text] [Related]

  • 11. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.
    Marks PA, Murate T, Kaneda T, Ravetch J, Rifkind RA.
    Symp Fundam Cancer Res; 1984 Feb 01; 37():327-40. PubMed ID: 6084863
    [Abstract] [Full Text] [Related]

  • 12. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z, Banks J, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1982 Jan 01; 79(2):471-5. PubMed ID: 6952199
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclin B, p34cdc2, and H1-kinase activity in terminally differentiating lens fiber cells.
    Gao CY, Bassnett S, Zelenka PS.
    Dev Biol; 1995 May 01; 169(1):185-94. PubMed ID: 7750637
    [Abstract] [Full Text] [Related]

  • 15. Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells.
    Michaeli J, Lebedev YB, Richon VM, Chen ZX, Marks PA, Rifkind RA.
    Mol Cell Biol; 1990 Jul 01; 10(7):3535-40. PubMed ID: 1972544
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in E2F DNA-binding activity during induced erythroid differentiation.
    Richon VM, Venta-Perez G.
    Cell Growth Differ; 1996 Jan 01; 7(1):31-42. PubMed ID: 8788031
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y, Buffolino P, Coppock DL.
    Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525
    [Abstract] [Full Text] [Related]

  • 19. Growth condition-induced precocious activation of p34cdc2 kinase inhibits the expression of developmental competence.
    Jantzen H, Schulze I.
    Dev Biol; 1994 Nov 01; 166(1):311-22. PubMed ID: 7958455
    [Abstract] [Full Text] [Related]

  • 20. Seric factors influence cell cycle modifications during commitment of murine erythroleukemia cells to differentiation.
    Mencherini F, Khochbin S, Chabanas A, Lawrence JJ.
    Cytometry; 1992 Nov 01; 13(5):518-24. PubMed ID: 1633731
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.